13F Pro Quality Score

56.4/100

Rank #1,100 of 2,879 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

48.2/100

Profitability

61.7/100

Balance Sheet

65.7/100

Earnings Quality

65.2/100

Free Cash Flow

81.5/100

Institutional Flow

56.4/100

Revenue Scale

29.9/100

Dilution Risk

36.1/100

HSTM Stock Analysis & AI Quality Score

AI stock analysis and institutional research for HEALTHSTREAM INC (HSTM), a Technology sector company. 13F Pro's AI-powered ranking engine scores HSTM at 56.4/100 on a 32-signal composite quality model, placing it at rank #1,100 of 2,879 stocks — the top half of the AI-ranked universe. HSTM scores in the top quartile across free cash flow (81.5). Areas of concern include revenue scale (29.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), HEALTHSTREAM INC reports quarterly revenue of $81.2M, net income of $5.9M, an operating margin of 9.3%. Top institutional holders of HSTM by reported 13-F value include BlackRock,, DIMENSIONAL FUND ADVISORS, Copeland Capital Management,, based on the most recent SEC filings. HSTM trades on the Nasdaq exchange and files with the SEC under CIK 1095565. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HSTM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HEALTHSTREAM INC directly from SEC EDGAR. HEALTHSTREAM INC's 13F Pro composite quality score has ranged between 8 and 61 since 2021, currently 56.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about HEALTHSTREAM INC

Quirks, history, and lore behind HSTM — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A software-as-a-service company · listed on Nasdaq · headquartered in Tennessee · serving a single, highly regulated industry.
  • 2
    The Numbers
    Annual revenue in the range of $270–290 million — not flashy, but steady — with a customer base of thousands of healthcare organizations across the U.S.
  • 3
    The History
    Founded in the early 1990s, it grew up alongside the internet and carved out a niche delivering training and education tools to hospitals at a time when most used binders and VHS tapes.
  • 4
    The Secret
    Its platform is essentially a learning management system built specifically for clinical and non-clinical hospital staff — think mandatory compliance training, but make it SaaS.
  • 5
    The Lore
    If a nurse at a major U.S. hospital had to complete an online certification module this year, there's a solid chance this company's platform delivered it — it reaches over 4 million healthcare workers.
  • 6
    The Giveaway
    Its name practically writes itself: it's the streaming platform for healthcare workforce learning, proudly traded under the ticker HSTM out of Nashville.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$81.2M

Net Income

Q1 2026

$5.9M

Free Cash Flow

Q1 2026

$26.4M

Operating Margin

Q1 2026

9.3%

ROIC

Q1 2026

2.1%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+9.0% YoY
$304.1MFY 2025
FY20 $244.8MFY22 $266.8MFY23 $279.1MFY25 $304.1M

Net Income

+20.6% YoY
$18.3MFY 2025
FY20 $14.1MFY22 $12.1MFY23 $15.2MFY25 $18.3M

Operating Income

+26.3% YoY
$20.2MFY 2025
FY20 $15.8MFY22 $12.4MFY23 $16.0MFY25 $20.2M

EPS (Diluted)

+22.0% YoY
$0.61FY 2025
FY20 $0.44FY22 $0.39FY23 $0.50FY25 $0.61

Total Assets

+4.1% YoY
$520.4MFY 2025
FY20 $500.3MFY22 $497.7MFY23 $499.9MFY25 $520.4M

Op. Cash Flow

-1.0% YoY
$63.3MFY 2025
FY20 $35.9MFY22 $51.2MFY23 $64.0MFY25 $63.3M

AI Insight: HSTM Financial Trends

HSTM revenue accelerated to $81M in Q1 2026 — highest in the dataset — while operating income rebounded sharply to $8M after a Q4 2025 dip.

Revenue grew steadily from $72M in Q2 2024 to $81M in Q1 2026, a 12.5% increase over seven quarters.

Operating income nearly doubled from $4M in Q2 2024 to $8M in Q1 2026, suggesting gradual margin expansion.

Operating cash flow surged to $27M in Q1 2026, matching the Q1 2025 peak and well above Q2 2025's trough of $5M.

Equity declined modestly from $363M in Q1 2025 to $352M in Q1 2026, a mild balance-sheet contraction.

Q4 2025 operating income collapsed to $2M — the lowest in the dataset — despite $80M revenue; cost pressures warrant scrutiny.

Operating cash flow is highly seasonal and volatile, swinging from $5M to $27M; sustainability of Q1 2026 levels is unclear.

Total debt data is absent across all periods, limiting full leverage and capital-structure assessment.

AI Insight: HSTM Ratio Trends

Q1 2026 operating margin rebounds sharply to 9.2% after Q4 2025's anomalous 3.0% trough, but TTM margin of 7.5% signals the Q4 dip is still dragging full-year profitability.

Operating margin recovered strongly from 3.0% in Q4 2025 to 9.2% in Q1 2026, the highest single-quarter reading in the dataset.

ROIC improved from 2.7% in Q4 2025 to 8.5% in Q1 2026, nearly matching Q3 2025's peak of 8.7%.

Q4 2025 saw a broad-based collapse across all metrics — OpMargin 3.0%, ROE 2.9%, ROIC 2.7% — well below any other quarter shown.

TTM NPM of 6.4% and ROA of 3.8% sit in the middle of the observed range, reflecting Q4 2025's drag on trailing figures.

Q4 2025's sharp margin collapse to 3.0% OpMargin remains unexplained — recurrence would materially impair full-year profitability.

TTM ROIC of 6.6% lags the Q1 2026 quarterly annualized rate of 8.5% — sustained Q4-style weakness could reverse the improving trend.

D/E data is entirely absent; leverage picture is unclear, limiting balance-sheet risk assessment.

Get alerted when HSTM's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for HEALTHSTREAM INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put HSTM on your watchlist

Track score changes the day HEALTHSTREAM INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HSTM a good stock to buy?

13F Pro's AI-powered analysis of HEALTHSTREAM INC (HSTM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HSTM are available on the HSTM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own HSTM?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HSTM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of HEALTHSTREAM INC's investment landscape.